• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖基化 HIV 天然样包膜三聚体 TLR 激动剂缀合物可保持中和表位。

Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.

机构信息

Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.

Department of Medical Microbiology, Amsterdam Institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, 1105AZ, Amsterdam, The Netherlands.

出版信息

Chembiochem. 2022 Aug 17;23(16):e202200236. doi: 10.1002/cbic.202200236. Epub 2022 Jun 20.

DOI:10.1002/cbic.202200236
PMID:35647713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9510654/
Abstract

Small molecule adjuvants are attractive for enhancing broad protection and durability of immune responses elicited by subunit vaccines. Covalent attachment of an adjuvant to an immunogen is particularly attractive because it simultaneously delivers both entities to antigen presenting cells resulting in more efficient immune activation. There is, however, a lack of methods to conjugate small molecule immune potentiators to viral glycoprotein immunogens without compromising epitope integrity. We describe herein a one-step enzymatic conjugation approach for the covalent attachment of small molecule adjuvants to N-linked glycans of viral glycoproteins. It involves the attachment of an immune potentiator to CMP-Neu5AcN by Cu(I)-catalyzed azide-alkyne 1,3-cycloaddition followed by sialyltransferase-mediated transfer to N-glycans of a viral glycoprotein. The method was employed to modify a native-like HIV envelope trimer with a Toll-like receptor 7/8 agonist. The modification did not compromise Env-trimer recognition by several broadly neutralization antibodies. Electron microscopy confirmed structural integrity of the modified immunogen.

摘要

小分子佐剂在增强亚单位疫苗引起的广泛保护和耐久性方面具有吸引力。将佐剂共价连接到免疫原上特别有吸引力,因为它同时将两者递送到抗原呈递细胞,从而更有效地激活免疫。然而,缺乏将小分子免疫增强剂与病毒糖蛋白免疫原缀合而不损害表位完整性的方法。本文描述了一种一步酶促偶联方法,用于将小分子佐剂共价连接到病毒糖蛋白的 N 连接糖上。它涉及通过 Cu(I)催化的叠氮化物-炔烃 1,3-环加成将免疫增强剂附着到 CMP-Neu5AcN 上,然后通过唾液酸转移酶介导转移到病毒糖蛋白的 N-糖上。该方法用于用 Toll 样受体 7/8 激动剂修饰天然样 HIV 包膜三聚体。修饰不会损害几种广泛中和抗体对 Env-三聚体的识别。电子显微镜证实了修饰后的免疫原的结构完整性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/46ff8c786bf5/CBIC-23-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/8b2eabb7ce61/CBIC-23-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/7a0a20e91bae/CBIC-23-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/8a34a64a2f16/CBIC-23-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/0e3c878b08ee/CBIC-23-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/46ff8c786bf5/CBIC-23-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/8b2eabb7ce61/CBIC-23-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/7a0a20e91bae/CBIC-23-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/8a34a64a2f16/CBIC-23-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/0e3c878b08ee/CBIC-23-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efca/9546345/46ff8c786bf5/CBIC-23-0-g003.jpg

相似文献

1
Conjugation of a Toll-Like Receptor Agonist to Glycans of an HIV Native-Like Envelope Trimer Preserves Neutralization Epitopes.糖基化 HIV 天然样包膜三聚体 TLR 激动剂缀合物可保持中和表位。
Chembiochem. 2022 Aug 17;23(16):e202200236. doi: 10.1002/cbic.202200236. Epub 2022 Jun 20.
2
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers .佐剂对 HIV-1 包膜糖蛋白 SOSIP 三聚体的影响。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00381-18. Print 2018 Jul 1.
3
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.闭合和打开 HIV-1 包膜糖蛋白 SOSIP 三聚体糖盾上的孔,可以将中和抗体反应重新引导到新暴露的表位上。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01656-18. Print 2019 Feb 15.
4
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.小鼠对裂解的可溶性HIV-1包膜三聚体的抗体反应在特异性上受到高度限制。
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
5
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.用 HIV-1 分 B 亚型 SOSIP 三聚体免疫的兔子产生的抗体可以通过破坏包膜糖蛋白来中和多种 B 亚型病毒。
J Virol. 2021 Aug 10;95(17):e0009421. doi: 10.1128/JVI.00094-21.
6
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.由精英中和抗体诱导的 HIV-1 包膜糖蛋白 SOSIP 三聚体产生的中和抗体反应。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01214-20.
7
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.可诱导细胞系产生含有以预触发构象稳定化的包膜糖蛋白的复制缺陷型人类免疫缺陷病毒颗粒。
J Virol. 2024 Dec 17;98(12):e0172024. doi: 10.1128/jvi.01720-24. Epub 2024 Nov 7.
8
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
9
Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.设计并鉴定一种缺乏 V1V2 环关键糖基的、天然样三聚体、种系靶向可溶性 HIV-1 Env。
Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129733. doi: 10.1016/j.bbagen.2020.129733. Epub 2020 Sep 16.
10
Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.去除保守的CD4结合位点近端聚糖导致的HIV-1包膜三聚体结构和抗原性变化
J Virol. 2016 Sep 29;90(20):9224-36. doi: 10.1128/JVI.01116-16. Print 2016 Oct 15.

本文引用的文献

1
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
2
Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides.自佐剂癌症疫苗由缀合准备脂质 A 类似物和合成长肽组成。
J Med Chem. 2020 Oct 22;63(20):11691-11706. doi: 10.1021/acs.jmedchem.0c00851. Epub 2020 Oct 6.
3
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates.
3M-052,一种合成的 TLR-7/8 激动剂,可在非人类灵长类动物中诱导持久的 HIV-1 包膜特异性浆细胞和体液免疫。
Sci Immunol. 2020 Jun 19;5(48). doi: 10.1126/sciimmunol.abb1025.
4
Site-specific glycan analysis of the SARS-CoV-2 spike.新冠病毒刺突蛋白的糖基化位点特异性分析。
Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.
5
Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses.具有内置佐剂的多功能蛋白质偶联物(佐剂-蛋白质-抗原)作为癌症疫苗可增强强效免疫反应。
iScience. 2020 Mar 27;23(3):100935. doi: 10.1016/j.isci.2020.100935. Epub 2020 Feb 24.
6
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen.病毒衍生的 HIV-1 包膜蛋白的位点特异性糖基化被可溶性三聚体免疫原模拟。
Cell Rep. 2018 Aug 21;24(8):1958-1966.e5. doi: 10.1016/j.celrep.2018.07.080.
7
Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake.代谢标记 HIV-1 包膜糖蛋白 gp120 以阐明 gp120 糖基化对抗原摄取的影响。
J Biol Chem. 2018 Sep 28;293(39):15178-15194. doi: 10.1074/jbc.RA118.004798. Epub 2018 Aug 16.
8
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.基于抗体鉴定、B 细胞发生和表位结构的 HIV-1 疫苗。
Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.
9
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.糖基工程化 HIV-1 Env 产生“超级充电”和“杂交”聚糖,以提高中和抗体的效力、广度和饱和度。
PLoS Pathog. 2018 May 2;14(5):e1007024. doi: 10.1371/journal.ppat.1007024. eCollection 2018 May.
10
Toll-like Receptor Agonist Conjugation: A Chemical Perspective. toll 样受体激动剂缀合:化学视角。
Bioconjug Chem. 2018 Mar 21;29(3):587-603. doi: 10.1021/acs.bioconjchem.7b00808. Epub 2018 Feb 16.